Brief: Biovaxys Announces Bioproduction Of Bvx-1021 For Its Pan-Sarbecovirus Program In Collaboration With Ohio State University
17/03/2022 13:37
March 17 (Reuters) - Biovaxys Technology Corp BIOV.CD :
* BIOVAXYS ANNOUNCES BIOPRODUCTION OF BVX-1021 FOR ITS
PAN-SARBECOVIRUS PROGRAM IN COLLABORATION WITH OHIO STATE
UNIVERSITY
Source text for Eikon: ID:nCNWV9SC0a
Further company coverage: BIOV.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biovaxys Technology
See all newsBrief: Biovaxys Appoints Former Sanofi Vaccines Executive To Board Of Directors
Brief: Biovaxys Announces Life Offering
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000